Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 6-7, Juin–Juillet 2012
Page(s) 580 - 582
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2012286008
Publié en ligne 16 juillet 2012
  1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999 ; 340 : 115–126. [CrossRef] [PubMed]
  2. Clarke MC, Talib S, Figg NL, Bennett MR. Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ Res 2010 ; 106 : 363–372. [CrossRef] [PubMed]
  3. Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010 ; 464 : 1357–1361. [CrossRef] [PubMed]
  4. Ridker PM, Thuren T, Zalewski A, Libby P. Interleukin-1 beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab anti-inflammatory thrombosis outcomes study (CANTOS). Am Heart J 2011 ; 162 : 597–605. [CrossRef] [PubMed]
  5. Mertens M, Singh JA. Anakinra for rheumatoid arthritis: a systematic review. J Rheumatol 2009 ; 36 : 1118–1125. [CrossRef] [PubMed]
  6. Lawrie A, Hameed AG, Chamberlain J, et al. Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. Am J Pathol 2011 ; 179 : 1693–1705. [CrossRef] [PubMed]
  7. Saxena A, Rauch U, Berg KE, et al. The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling. Cardiovasc Res 2011 ; 91 : 350–357. [CrossRef] [PubMed]
  8. Alexander MR, Moehle CW, Johnson JL, et al. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice. J Clin Invest 2012 ; 122 : 70–79. [CrossRef] [PubMed]
  9. Lacolley P, Regnault V, Nicoletti A, et al. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 2012 (sous-presse).
  10. Ait-Oufella H, Salomon BL, Potteaux S, et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat Med 2006 ; 12 : 178–180. [CrossRef] [PubMed]
  11. Caligiuri G, Nicoletti A, Poirier B, Hansson GK. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J Clin Invest 2002 ; 109 : 745–753. [CrossRef] [PubMed]
  12. Ho-Tin-Noé B, Le Dall J, Gomez D, et al. Early atheroma-derived agonists of peroxisome proliferator-activated receptor-γ trigger intramedial angiogenesis in a smooth muscle cell-dependent manner. Circ Res 2011 ; 109 : 1003–1014. [CrossRef] [PubMed]
  13. Le Dall J, Ho-Tin-Noé B, Louedec L, et al. Immaturity of microvessels in haemorrhagic plaques is associated with proteolytic degradation of angiogenic factors. Cardiovasc Res 2010 ; 85 : 184–193. [CrossRef] [PubMed]
  14. Tréguer K, Heydt S, Hergenreider E. Protection des vaisseaux sanguins contre l’athérosclérose : le rôle des miARN sécrétés par l’endothélium. Med Sci (Paris) 2012 ; 28 : 584–587. [CrossRef] [EDP Sciences] [PubMed]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.